I think maybe the money's what's throwing you off here today.
Followers | 199 |
Posts | 17,208 |
Boards Moderated | 2 |
Alias Born | 02/17/2012 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lotto time.
GLCO
GLCO Moving
GLCO Moving
GLCO .0039 x .004
BARK moving
Word on the street, there’s a pulse.
Nice action with the spread. Tightening up.
GLCO
GLCO Volume
$GLCO .0041 Resistance
GLCO .0037 x .0039
GLCO .0037 x .0039
TRIT shorts hurtin for a squirtin.
TRIT shorts hurtin for a squirtin.
GLCO bid/ask heating up on filing rumor.
GLCO bid/ask heating up on filing rumor.
GLCO volume coming in
GLCO // Been waiting patiently.
GLCO Volume coming in
OCGN FDA NEWS IMMINENT
“I’m thrilled to be part of the Ocugen team and share the team’s dedication to save lives from COVID-19. Bringing COVAXIN to the US market will be an important addition to our national arsenal of vaccines against COVID-19,” said J.P. Gabriel, SVP, Manufacturing and Supply Chain of Ocugen.”
IMMP Interesting action....
IMMP interesting action.
After all these years, only two million?
Hope all is well.
Exactly. Well said.
OCGN
$OCGN // THE PRIME MINISTER OF INDIA CHOSE COVAXIN!!!
Maybe..... because interim Phase 3 results are ready......
https://www.hindustantimes.com/india-news/pm-modi-takes-first-dose-of-covid-19-vaccine-101614562713018.html
Options are open on this “stinky pinky.”
“MICT Obtains Security Trading License In China, Hong Kong Via Huapei Global Securities Acquisition”
https://www.benzinga.com/node/19855594
FCGD On watch
MICT Laundry list of recent institutional buys up to 3.10
SNDL is far from over imo.
“Dr. Shankar Musunuri will provide an update on COVAXIN™ development and on our ophthalmology pipeline at @bio1x1's CEO & Investor #Digital Conference on February 16-18. Register to gain access to our presentation here: ow.ly/URFZ50DqBVe $OCGN #BIOCEO21”
https://twitter.com/ocugen/status/1360273090312368129?s=21
GLCO .0058 Slap
GLCO priming up.
GLCO Gettin legs